Volume 72, Issue 6 | Pharmacological Reports

Search all Pharmacological Reports articles

Volume 72, Issue 6

December 2020

COVID-19 - insights on pharmacology and pharmacotherapy

28 articles in this issue

Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
Marek Sanak
Editorial 18 November 2020 Pages: 1445 - 1445
Pharmacological treatments of COVID-19
Adeleh Sahebnasagh
Razieh Avan
Amirhosein Khoshi
Review 20 August 2020 Pages: 1446 - 1478
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh
Subhashree Parida
Raj Kumar Singh
Review 05 September 2020 Pages: 1479 - 1508
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
Moshe Rogosnitzky
Paul Okediji
Igor Koman
Review Open access 22 July 2020 Pages: 1509 - 1516
Overview of the possible role of vitamin C in management of COVID-19
Anis Abobaker
Aboubaker Alzwi
Alsalheen Hamed A. Alraied
Review 28 October 2020 Pages: 1517 - 1528
The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
Carmen de Cáceres
Rodrigo Martínez
José Manuel García
Article 09 November 2020 Pages: 1529 - 1537
Observational study of people infected with SARS-Cov-2, treated with amantadine
Gonzalo Emiliano Aranda-Abreu
José D. Aranda-Martínez
Fausto Rojas-Durán
Short Communication 10 October 2020 Pages: 1538 - 1541
Favipiravir use for SARS CoV-2 infection
Alberto Boretti
Short Communication 27 October 2020 Pages: 1542 - 1552
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis
Krzysztof Marciniec
Artur Beberok
Dorota Wrześniok
Short Communication Open access 15 October 2020 Pages: 1553 - 1561
Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice
Ewa Poleszak
Sylwia Wośko
Anna Serefko
Original Paper Open access 27 March 2020 Pages: 1562 - 1572
Three neurosteroids as well as GABAergic drugs do not convert immediate postictal potentiation to depression in immature rats
Pavel Mareš
Eva Kudová
Hana Kubová
Article 08 June 2020 Pages: 1573 - 1578
Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes
Agata Ciechanowska
Katarzyna Popiolek-Barczyk
Joanna Mika
Article Open access 13 November 2020 Pages: 1579 - 1592
Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission
Monika Herian
Adam Wojtas
Krystyna Gołembiowska
Article Open access 10 November 2020 Pages: 1593 - 1603
Interplay of curcumin and its liver metabolism on the level of Aβ in the brain of APP_swe/PS1_dE9 mice before AD onset
Xi Mei
Lina Zhu
Zhongming Chen
Article 28 May 2020 Pages: 1604 - 1613
Blockade of the colony-stimulating factor-1 receptor reverses bone loss in osteoporosis mouse models
Arisaí Martínez-Martínez
Enriqueta Muñoz-Islas
Juan M. Jiménez-Andrade
Article 28 March 2020 Pages: 1614 - 1626
Chronic hyperglycemia impairs mitochondrial unfolded protein response and precipitates proteotoxicity in experimental diabetic neuropathy: focus on LonP1 mediated mitochondrial regulation
Anil Kumar Kalvala
Veera Ganesh Yerra
Ashutosh Kumar
Article 27 July 2020 Pages: 1627 - 1644
Fenofibrate ameliorates testicular damage in rats with streptozotocin-induced type 1 diabetes: role of HO-1 and p38 MAPK
Asmaa Mohamed Abdel-Aziz
Samah Mohammed Mahmoud Abozaid
Hanaa Mohamed Khalaf
Article 09 June 2020 Pages: 1645 - 1656
Tropisetron attenuates pancreas apoptosis in the STZ-induced diabetic rats: involvement of SIRT1/NF-κB signaling
Roya Naderi
Alireza Shirpoor
Azam Moslehi
Article 28 July 2020 Pages: 1657 - 1665
The role of spinally located dopamine D₂ receptors in the regulation of the blood glucose level in mice
JaeSeung Hong
JingHui Feng
HongWon Suh
Article 05 July 2020 Pages: 1666 - 1675
Low-dose angiotensin AT₁ receptor β-arrestin-biased ligand, TRV027, protects against cisplatin-induced nephrotoxicity
Abdolhamid Esmaeeli
Fatemeh Ebrahimi
Mohammad Seyedabadi
Article 22 October 2020 Pages: 1676 - 1684
The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions
Przemysław J. Danek
Jacek Wójcikowski
Władysława A. Daniel
Article Open access 11 April 2020 Pages: 1685 - 1694
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s
Máté Tamás Déri
Ádám Ferenc Kiss
Katalin Monostory
Article Open access 08 July 2020 Pages: 1695 - 1705
The effect of forskolin on membrane clock and calcium clock in the hypoxic/reoxygenation of sinoatrial node cells and its mechanism
Jian-cheng Zhang
Xiao-ting Xie
Peng-li Zhu
Article 25 May 2020 Pages: 1706 - 1716
Effects of the synthetic cannabinoid XLR-11 on the viability and migration rates of human brain microvascular endothelial cells in a clinically-relevant model
Laith AL-Eitan
Ahmed Alhusban
Saif Alahmad
Article 06 July 2020 Pages: 1717 - 1724
Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function
Eloisa Aparecida Vilas-Boas
Noémie Karabacz
Leticia Prates Roma
Article Open access 09 April 2020 Pages: 1725 - 1737
Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
Zuhal Alım
Zeynep Köksal
Muhammet Karaman
Article 03 August 2020 Pages: 1738 - 1748
Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy
K. Laxmi Swetha
Swati Sharma
Aniruddha Roy
Article 02 July 2020 Pages: 1749 - 1765
Thyroid hormones reduce nicotinic receptor mediated currents in SH-SY5Y neuroblastoma cells
Giulia Puia
Federica Ravazzini
Short Communication 21 October 2020 Pages: 1766 - 1771